Transjugular intrahepatic portosystemic shunt (TIPS) placement is a well-studied treatment for symptomatic portal hypertension. Model for End-Stage Liver Disease (MELD), MELD-NA and MELD 3.0 have all been utilized to provide pre-TIPS risk stratification. However, racial demographics remain an understudied area in terms of outcomes following TIPS.
What's Your Reaction?






